Abstract

Type-2 Diabetes Mellitus (T2DM) poses a significant global health burden, affecting millions worldwide. Despite extensive research, current treatment options often fall short in managing this complex metabolic disorder. Recently, there has been growing interest in the role of the gut microbiome in T2DM pathogenesis, presenting a promising avenue for novel therapeutic interventions. This article explores the intricate relationship between the gut microbiome and T2DM, highlighting emerging research on microbiome modulation as a potential therapeutic strategy.